{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:45:22Z","timestamp":1790667922181,"version":"4.1.0"},"reference-count":29,"publisher":"Japanese Society of Toxicology","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2131\/jts.39.765","type":"journal-article","created":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T23:21:10Z","timestamp":1411168870000},"page":"765-774","source":"Crossref","is-referenced-by-count":48,"title":["Cisplatin (CDDP) triggers cell death of MCF-7 cells following disruption of intracellular calcium ([Ca&lt;sup&gt;2+&lt;\/sup&gt;]&lt;sub&gt;i&lt;\/sub&gt;) homeostasis"],"prefix":"10.2131","volume":"39","author":[{"given":"Nawaf","family":"Al-Taweel","sequence":"first","affiliation":[{"name":"Weill Cornell Medical College in Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Varghese","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College in Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Maria","family":"Florea","sequence":"additional","affiliation":[{"name":"Institute of Neuropathology, Heinrich-Heine University D\u00fcsseldorf"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich","family":"B\u00fcsselberg","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College in Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Biersack, B., Ahmad, A., Sarkar, F.H. and Schobert, R. (2012): Coinage metal complexes against breast cancer. Curr. Med. Chem., <b>19<\/b>, 3949-3956.","DOI":"10.2174\/092986712802002482"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Carafoli, E., Santella, L., Branca, D. and Brini, M. (2001): Generation, control, and processing of cellular calcium signals. Crit. Rev. Biochem. Mol. Biol., <b>36<\/b>, 107-260.","DOI":"10.1080\/20014091074183"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Cobleigh, M.A. (2011): Other options in the treatment of advanced breast cancer. Semin Oncol., <b>38<\/b>, S11-16. doi. 10.1053\/j. seminoncol.2011.04.005.","DOI":"10.1053\/j.seminoncol.2011.04.005"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Colombo, P.E., Milanezi, F., Weigelt, B. and Reis-Filho, J.S. (2011): Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction. Breast Cancer Res., <b>13<\/b>, 212.","DOI":"10.1186\/bcr2890"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Dumitrescu, R.G. and Cotarla, I. (2005): Understanding breast cancer risk -- where do we stand in 2005? J. Cell. Mol. Med., <b>9<\/b>, 208-221.","DOI":"10.1111\/j.1582-4934.2005.tb00350.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Eckstein, N. and Haas, B. (2012): [Platinum-based chemotherapy in triple negative breast cancer]. [Article in German] Dtsch. Med. Wochenschr., <b>137<\/b>, 333-336. doi: 10.1055\/s-0031-1298891.","DOI":"10.1055\/s-0031-1298891"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Florea, A.-M. and B\u00fcsselberg, D. (2011): Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects. Cancers, <b>3<\/b>, 1351-1371. doi:10.3390\/cancers3011351.","DOI":"10.3390\/cancers3011351"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Florea, A.-M. and B\u00fcsselberg, D. (2012): Metals and Breast cancer: Risk factors or Healing agents? J. Toxicol., Special Issue \u201cMetals and disease\u201d, ID 825354, doi:10.1155\/2012\/825354.","DOI":"10.1155\/2012\/825354"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Florea, A.-M. and B\u00fcsselberg, D. (2013): Breast cancer and possible mechanisms of therapy resistance. Journal of Global and Local Health Science Vol. 2013, 2.","DOI":"10.5339\/jlghs.2013.2"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Florea, A.-M., Dopp, E. and Busselberg, D. (2005): Elevated [Ca<sup>2+<\/sup>]<sub>i<\/sub> transients induced by trimethyltin chloride in HeLa cells: types and levels of response. Cell Calcium, <b>37<\/b>, 251-258.","DOI":"10.1016\/j.ceca.2004.10.005"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Florea, A.-M. and Busselberg, D. (2006): Occurrence, use and potential toxic effects of metals and metal compounds. Biometals, <b>19<\/b>, 419-427.","DOI":"10.1007\/s10534-005-4451-x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Florea, A.M., Splettstoesser, F. and Busselberg, D. (2007): Arsenic trioxide (As<sub>2<\/sub>O<sub>3<\/sub>) induced calcium signals and cytotoxicity in two human cell lines: SY-5Y neuroblastoma and 293 embryonic kidney (HEK). Toxicol. Appl. Pharmacol., <b>220<\/b>, 292-301.","DOI":"10.1016\/j.taap.2007.01.022"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Florea, A.-M. and Busselberg, D. (2008): Arsenic trioxide in environmentally and clinically relevant concentrations interacts with calcium homeostasis and induces cell type specific cell death in tumor and non-tumor cells. Toxicol. Lett., <b>179<\/b>, 34-42.","DOI":"10.1016\/j.toxlet.2008.03.019"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Florea, A.-M. and Busselberg, D. (2009a): Anti-cancer drugs interfere with intracellular calcium signaling. Neurotoxicology, <b>30<\/b>, 803-810.","DOI":"10.1016\/j.neuro.2009.04.014"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Florea, A.-M. and Busselberg, D. (2009b): Metallic compounds (arsenic trioxide and trimethyltin chloride) interact with calcium homeostasis and trigger cell death in \u201c<i>in vitro<\/i>\u201d systems. Mat.-wiss. u. Werkstofftech., <b>40<\/b>, 13-16.","DOI":"10.1002\/mawe.200800371"},{"key":"16","doi-asserted-by":"crossref","unstructured":"G\u00fcnes, D.A., Florea, A.M., Splettstoesser, F. and Busselberg, D. (2009): Co-application of arsenic trioxide (As<sub>2<\/sub>O<sub>3<\/sub>) and cisplatin (CDDP) on human SY-5Y neuroblastoma cells has differential effects on the intracellular calcium concentration [Ca<sup>2+<\/sup>]<sub>i<\/sub> and cytotoxicity. Neurotoxicology, <b>30<\/b>, 194-202.","DOI":"10.1016\/j.neuro.2008.12.001"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Hurley, J., Reis, I.M., Rodgers, S.E., Gomez-Fernandez, C., Wright, J., Leone, J.P., Larrieu, R. and Pegram, M.D. (2013): The use of neoadjuvant platinum-based chemotherapy in locally advanced breast cancer that is triple negative: retrospective analysis of 144 patients. Breast Cancer Res. Treat., <b>138<\/b>, 783-794. doi: 10.1007\/s10549-013-2497-y.","DOI":"10.1007\/s10549-013-2497-y"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Joensuu, H. and Gligorov, J. (2012): Adjuvant treatments for triple-negative breast cancers. Ann. Oncol., <b>23<\/b>, vi40-5.","DOI":"10.1093\/annonc\/mds194"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Lipskaia, L. and Lompr\u00e9, A. M. (2004): Alteration in temporal kinetics of Ca2+ signaling and control of growth and proliferation. Biol. Cell, <b>96<\/b>, 55-68.","DOI":"10.1016\/j.biolcel.2003.11.001"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Monteith, G.R., McAndrew, D., Faddy, H.M. and Roberts-Thomson, S.J. (2007): Calcium and cancer: targeting Ca<sup>2+<\/sup> transport. Nat. Rev. Cancer, <b>7<\/b>, 519-530.","DOI":"10.1038\/nrc2171"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Motiani, R.K., Stolwijk, J.A., Newton, R.L., Zhang, X., Trebak, M. (2013): Emerging roles of Orai3 in pathophysiology. Channels (Austin), <b>7<\/b>, 392-401.","DOI":"10.4161\/chan.24960"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Muscella, A., Calabriso, N., Vetrugno, C., Fanizzi, F.P., De Pascali, S.A., Storelli, C. and Marsigliante, S. (2011): The platinum (II) complex [Pt(O,O\u2019-acac)(\u03b3-acac)(DMS)] alters the intracellular calcium homeostasis in MCF-7 breast cancer cells. Biochem. Pharmacol., <b>81<\/b>, 91-103. doi: 10.1016\/j.bcp.2010.09.012.","DOI":"10.1016\/j.bcp.2010.09.012"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Normanno, N., Morabito, A., De Luca, A., Piccirillo, M.C., Gallo, M., Maiello, M.R. and Perrone, F. (2009). Target-based therapies in breast cancer: current status and future perspectives. Endocr. Relat. Cancer, <b>16<\/b>, 675-702.","DOI":"10.1677\/ERC-08-0208"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Prabhakaran, P., Hassiotou, F., Blancafort, P. and Filgueira, L. (2013): Cisplatin induces differentiation of breast cancer cells. Front. Oncol., <b>3<\/b>, 134. doi: 10.3389\/fonc.2013.00134.","DOI":"10.3389\/fonc.2013.00134"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Shamseddine, A.I. and Farhat, F.S. (2011): Platinum-based compounds for the treatment of metastatic breast cancer. Chemotherapy, <b>57<\/b>, 468-487. doi: 10.1159\/000334093.","DOI":"10.1159\/000334093"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Splettstoesser, F., Florea, A.-M. and B\u00fcsselberg, D. (2007): IP(3) receptor antagonist, 2-APB, attenuates cisplatin induced Ca<sup>2+<\/sup>- influx in HeLa-S3 cells and prevents activation of calpain and induction of apoptosis. Brit. J. Pharmacology,<b> 151<\/b>, 1176-1186.","DOI":"10.1038\/sj.bjp.0707335"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Szatkowski, C., Parys, J.B., Ouadid-Ahidouch, H. and Matifat, F. (2010): Inositol 1,4,5-trisphosphate-induced Ca<sup>2+<\/sup> signalling is involved in estradiol-induced breast cancer epithelial cell growth. Mol. Cancer, <b>9<\/b>, 156. doi: 10.1186\/1476-4598-9-156.","DOI":"10.1186\/1476-4598-9-156"},{"key":"28","doi-asserted-by":"crossref","unstructured":"van \u2018t Veer, L.J., Dai, H., van de Vijver, M.J., He, Y.D., Hart, A.A., Mao, M., Peterse, H.L., van der Kooy, K., Marton, M.J.,Witteveen, A.T., Schreiber, G.J., Kerkhoven, R.M., Roberts, C., Linsley, P.S., Bernards, R. and Friend, S.H. (2002). Gene expression profiling predicts clinical outcome of breast cancer. Nature, <b>415<\/b>, 530-536.","DOI":"10.1038\/415530a"},{"key":"29","unstructured":"Zhang, W., Couldwell, W.T., Song, H., Takano, T., Lin, J.H. andNedergaard, M. (2000): Tamoxifen-induced enhancement of calcium signaling in glioma and MCF-7 breast cancer cells. Cancer Res., <b>60<\/b>, 5395-5400."}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/39\/5\/39_765\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T12:55:13Z","timestamp":1650200113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/39\/5\/39_765\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.39.765","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}